4.4 Article

Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn's Disease

期刊

DIGESTIVE DISEASES AND SCIENCES
卷 64, 期 8, 页码 2280-2285

出版社

SPRINGER
DOI: 10.1007/s10620-019-05553-2

关键词

Crohn's disease; Malabsorption syndromes; Parenteral nutrition; Incidence; Risk factors

资金

  1. Astellas Pharma [IDRS2017A000577]

向作者/读者索取更多资源

BackgroundIntestinal failure is the most critical complication of Crohn's disease. Intestinal failure requires home parenteral nutrition, which worsens the quality of life of the patients and sometimes causes life-threatening complications.AimsThe purpose of this study was to investigate the incidence and risk factors for intestinal failure in Crohn's disease.MethodsWe performed a retrospective analysis of Crohn's disease patients (162 cases) at Osaka University Hospital between January 2000 and December 2017. Kaplan-Meier analysis was used to investigate the cumulative incidence of intestinal failure. To identify the risk factors of intestinal failure, patient characteristics were analyzed by multivariate analysis, including disease classification, surgical history, medical treatment other than surgery, and cumulative inflammation was calculated using the average C-reactive protein value and disease duration.ResultsThe cumulative incidence of intestinal failure 5, 10, and 15years after Crohn's disease diagnosis was 2.6%, 3.4%, and 8.6%, respectively. Multivariate analysis identified the following as independent risk factors for intestinal failure in Crohn's disease: residual small intestinal length <200cm (odds ratio 7.51, 95% confidence interval 2.14-29.96), non-use of anti-tumor necrosis factor-alpha therapy (3.34, 1.22-10.74), and cumulative inflammation (1.01, 1.001-1.038). We created a new predictive nomogram consisting of these risk factors.ConclusionsIntestinal failure occasionally occurred during long-term treatment of Crohn's disease. Cumulative inflammation for the first time, in addition to short residual small intestinal length and non-use of anti-tumor necrosis factor-alpha therapy, was shown to be potential risk factors for intestinal failure in Crohn's disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据